Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127146) titled 'Clinical Observation on the Adjuvant Analgesic Effect of Nalbuphine After Laparoscopic Myomectomy: A Prospective Randomized Controlled Trial' on June 25.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Obstetrics & Gynecology Hospital of Fudan University ,Yangtze River Delta Integration Demonstration Zone(QingPu)
Condition:
Uterine Leiomyoma
Intervention:
Study group:At 4 hours after operation, nalbuphine 2 mg was diluted with normal saline to 100 mL for intravenous infusion at a rate of 40-50 drops per minute, administered twice daily for 3 consecutive days.
Recruitment Status: Re...